Rita, Indo-Pacific bottlenose dolphin at Hong Kong's Ocean Park, dies at 24
The marine mammal had lived in the park for about 13 years after she was transferred from Tunisia. Investigations into her death are ongoing.
'Rita was a playful animal who got along well with her dolphin and human mates, and was a beloved animal ambassador living in the Marine Mammal Breeding and Research Centre next to the Ocean Park Veterinary Centre,' a park spokesman said.
Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.
She had refused to eat and showed signs of tiredness since Friday.
The park said that veterinarians performed thorough examinations and blood tests on the dolphin, which caretakers looked after around the clock.
But her health conditions worsened and she died on Sunday afternoon.
The park has conducted a necropsy to determine the cause of death, while further laboratory tests are under way.
The spokesman said that students had learned about and appreciated the natural behaviour and daily care of dolphins up close through guided tours, and were inspired to contribute to marine conservation.
'The park expresses its gratitude to Rita for conveying conservation messages to visitors. She will forever hold a special place in our hearts and memories,' he said.
Rita was transferred to Hong Kong from Friguia Park in Tunisia in November 2012, after the facility closed its dolphin show, according to Ceta-Base, an online database of captive-held cetaceans across the world.
She gave birth to a male calf named Rati in September 2015.
In 2021, Ocean Park announced that Milo, a seven-year-old female Indo-Pacific bottlenose dolphin, died after suffering acute haemorrhagic enteritis, or inflammation of the intestines.
More from South China Morning Post:
For the latest news from the South China Morning Post download our mobile app. Copyright 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
3 days ago
- The Sun
Malaysia leads global medical device regulatory reliance with China
KUALA LUMPUR: Malaysia has achieved a major milestone in global healthcare regulation with the launch of the Medical Device Regulatory Reliance Programme in partnership with China. The initiative, led by the Medical Device Authority Malaysia (MDA), marks a strategic leap in streamlining approvals for medical devices between the two nations. MDA chief executive Dr P. Muralitharan stated that the programme allows mutual recognition of pre-market approvals, significantly reducing processing times. Malaysian in-vitro diagnostic (IVD) devices will now qualify for China's Green Channel, while Chinese devices can utilise Malaysia's Verification Pathway, cutting approval periods to 60 and 30 working days, respectively. 'This collaboration eliminates regulatory duplication, speeds up market entry, and ensures faster patient access to advanced medical technologies,' Muralitharan said. 'It also solidifies Malaysia's reputation as a regional regulatory leader and boosts investor trust in our healthcare ecosystem.' The programme was unveiled at the Healthcare Information and Management Systems Society Asia-Pacific (HIMSS APAC) Health Conference & Exhibition 2025, following a memorandum of understanding signed between MDA and China's National Medical Products Administration (NMPA) in November 2023. Muralitharan encouraged industry players to engage with MDA for further details, emphasising the programme's role in fostering efficient and transparent healthcare regulation. The initiative officially begins on July 30, reinforcing Malaysia's commitment to global health innovation. - Bernama
Barnama
07-07-2025
- Barnama
KPJ Healthcare Clinches 15 Awards At GHAPAC 2025, Reaffirms Regional Leadership
Chief Marketing Officer of KPJ Healthcare Berhad, Sherene Azli (third, left) together with Team KPJ at the GlobalHealth Asia-Pacific Summit, Conference and Awards 2025. (Credit: KPJ Healthcare) KUALA LUMPUR, July 7 (Bernama) -- KPJ Healthcare Berhad reaffirmed its position as a regional leader in patient-centred, tech-driven care by emerging as the most awarded healthcare group at the 2025 GlobalHealth Asia-Pacific (GHAPAC) Awards, held recently in Bangkok, Thailand. In a statement today, KPJ Healthcare announced it had clinched a total of 15 awards, reinforcing its standing as a regional leader in patient-centred, technology-driven care. KPJ Healthcare president and managing director Chin Keat Chyuan said the recognition was a testament to the dedication and teamwork spirit across the group's network. "Being recognised across such a wide range of specialties shows the depth of our clinical capabilities and our continuous efforts to improve. "Guided by our purpose of Care for Life, we remain focused on delivering world-class care that is powered by innovation and compassion," he said in the statement. Held alongside the GlobalHealth Asia-Pacific Summit and Conference, the GHAPAC Awards honoured excellence in clinical innovation, healthcare service delivery and medical technology across the region. Seven KPJ hospitals were recognised across various clinical disciplines, reinforcing the group's leadership in specialised care and service excellence. KPJ Tawakkal KL Specialist Hospital earned four major honours for Diagnostic Imaging Centre of the Year, Ear, Nose, and Throat (ENT) Service Provider of the Year, Urology Service Provider of the Year, and Brain and Spine Service Provider of the Year. Damansara Specialist Hospital 2 picked up three key honours: Minimal Invasive Cardiac Surgery of the Year, Smart Hospital of the Year, and Cardiology Service Provider of the Year.
The Star
29-06-2025
- The Star
Godiva ordered by Hong Kong govt to halt dark chocolate ice cream sale after bacteria find
Hong Kong authorities have ordered a branch of Belgian luxury chocolatier Godiva to halt the sale of its dark chocolate soft ice cream after a sample was found to contain a bacterial count 46 times above the legal limit. The Centre for Food Safety said on Thursday that the sample collected from the shop at Cityplaza in Tai Koo had 2.3 million bacteria per gram – 46 times higher than the legal limit of 50,000. 'The centre has informed the vendor involved of the irregularity and instructed it to stop selling and immediately dispose of the affected product,' a spokesman said. 'Prosecution will be instituted should there be sufficient evidence.' Under the Frozen Confections Regulation, those convicted of selling frozen confections with bacterial levels exceeding the legal limit face a maximum penalty of a fine of HK$10,000 (US$1,273) and three months' imprisonment. The spokesman said the centre had asked Godiva to carry out a thorough cleaning and disinfection. He added that the centre had also provided health education on food safety and hygiene to the vendor's representative and staff. The centre also noted that the total bacterial count exceeding the legal limit indicated unsatisfactory hygienic conditions, but that did not mean that consumption would lead to food poisoning. - SOUTH CHINA MORNING POST
